IngredientsPu-erh tea is a kind of special post-fermented tea, originally produced in Yunnan province of China for about 1,700 years. It is obtained by first parching crude green tea leaves (Camellia sinensis var. assamica (L.) Family: Theaceae) and then it undergoes a secondary fermentation with microorganisms such as Aspergillus sp. All types of pu-erh tea are created from máochá (毛茶), a mostly unoxidized green tea processed from a "large leaf" variety of Camellia sinensis (C. sinensis var. assamica or C. taliensis) found in the mountains of southern Yunnan.
Pu-erh tea is classified within the broader category of Chinese dark teas (hēichá, 黑茶), a category defined by post-fermentation. Because of the cultural significance of pu'er tea, its unique cultivation process, and the unbroken history of growing tea at Jingmai Mountain, it was inscribed as a UNESCO World Heritage Site in 2023.
The tea is spelled variously as pu-erh, pu'er, puer, or puerh in English romanization. The Chinese characters 普洱茶 (pǔ'ěr chá) literally refer to the town of Pu'er in Yunnan, which served as the historical trading hub. During the Wanli era of the Ming Dynasty, Xie Zhaozhe mentioned the term "Pu tea" (i.e., Pu-erh Tea) in his work Dian Lue. The book states: "What the gentry and commoners all use is Pu tea, steamed and formed into cakes." This is the first written record of the term "Pu tea."
Pu-erh tea is commercially available in several physical forms. Pu-erh traditionally begins as a raw product known as "rough" Mao Cha (毛茶) and can be sold in this form or pressed into a number of shapes and sold as "raw" Sheng Cha (生茶). Both of these forms then undergo the complex process of gradual fermentation and maturation with time.
The recently developed Wo Dui process (渥堆) pioneered by both the Menghai and Kunming Tea Factories has created a new type of pu-erh tea. This process involves an accelerated fermentation into "ripe" Shou Cha (熟茶) which is then sold loose or pressed in various shapes.
Brewed as an infusion, this variety comes in several distinct forms: loose-leaf, compressed into flat cakes, or shaped into nests known as TuoCha. Loose-leaf post-fermented tea ages more quickly than compressed cakes or nests, and is therefore slightly less easy to store over time.
Beyond traditional loose-leaf and compressed forms, pu-erh is also available commercially as a standardized dry extract in capsule or tablet form. Studies have evaluated the effects of daily consumption of Puer tea extract (PTE) on body weight, body-fat composition, and lipid profile in a non-Asian population, using a randomized, double-blind, placebo-controlled study design.
Pu-erh tea was originally produced in the Yunnan province of China for about 1,700 years. Li Shizhen's Compendium of Materia Medica from the Ming Dynasty contains the record: "Pu-erh Tea comes from Pu'er in Yunnan." Ruan Fu of the Qing Dynasty wrote in Pu'er Tea Record: "The use of Pu'er by the Western Fan (Tibetans) dates back to the Tang Dynasty."
The history of Menghai black tea in Yunnan begins under the Tang dynasty. It was then a trade product between Chinese and Tibetan merchants. It is likely that the tea leaves fermented during expeditions.
The Tea Horse Road connected brick tea from Sichuan and pu'er tea from Yunnan to Tibet after a three- to six-month-long overland journey, where tea was traded for Tibetan horses. The history of the Tea and Horse Road can be traced to the era of the Tang Dynasty (618–907 CE) in China and the Tubo Period (7th–9th century CE) in Tibet. The Southwest Silk Road through Yunnan opened in the seventh century CE and is known by historians as the "Tea Horse Road."
In Tibet, tea bricks were boiled into butter tea — rich in yak butter and salt. In Inner Mongolia, nomadic cultures brewed salty milk tea with strong, compressed tea leaves. The compressed cake format was therefore both an economic and logistical adaptation, enabling months of transport across high-altitude terrain without spoilage.
Concentrated Pu'er tea cubes were highly regarded by the Qing imperial court for their medicinal properties and were even included in the Chinese medical book Compendium of Materia Medica Sequel. Under the Chinese Ming Empire, Pu-erh teas fell from grace. However, in the confines of Yunnan, in Menghai, the cultivation of organic tea cake continued. When the Qing took Chinese power, Yunnan black tea regained a place of honor. It was then renamed "Pu Erh tea."
During the Tang Dynasty (618–907 AD), Pu-erh tea gained significant popularity as a medicinal beverage. It was often prescribed by imperial physicians to treat digestive issues and hangovers among the nobility.
It was recorded in the Compendium of Materia Medica that Pu-erh tea can expel wind-evil, clear away heat, and aid in losing weight. Pu-erh tea is widely believed in Chinese cultures to counteract the unpleasant effects of heavy alcohol consumption. In traditional Chinese medicine it is believed to invigorate the spleen and inhibit "dampness." In the stomach, it is believed to reduce heat and "descend qi."
In TCM, Pu-erh tea is classified as a "warm" and "yang" substance. This classification means it is believed to promote circulation and boost metabolism. These are traditional attributions within the TCM framework and are not equivalent to pharmacological claims validated by clinical evidence.
The wòduī (渥堆) fermentation process was developed in 1973 by the Kunming Tea Factory, creating a new type of pu'er tea. This process involves an accelerated fermentation into shóu chá/shú chá (熟茶; 'ripe tea') that is then stored loose or pressed into various shapes. The fermentation process was adopted at the Menghai Tea Factory shortly after and technically developed there. Shou (ripe) pu-erh tea was first made in the 1970s, still in Yunnan, as an attempt to make a cheaper and shorter version of sheng (raw) pu-erh tea.
Sheng (raw) pu-erh tea's process is similar to green tea — withering, pan-frying, rolling, drying — but is then compressed, often into cakes or discs. After compressing, it is carefully stored and aged for future consumption. This process may take years, with the rarest sheng pu-erh teas being fermented for up to 30 years for the highest quality.
In the production of ripe Pu-erh, fermentation takes place before pressing. Producers accelerate it by spreading the tea on the ground, moistening it with water, then covering it with a tarpaulin for a minimum of 45 days. Micro-organisms work to transform the tea, creating the post-fermented result.
Pu-erh tea mainly contains proteins and amino acids (phenylalanine, L-theanine, glutamine, histidine), carbohydrates (soluble sugars, polysaccharides), volatiles (alcohols, hydrocarbons, and ketones), minerals (Mg, Mn, Fe), phenolic compounds [phenolic acids, flavonoids (flavonol, flavan-3-ol, flavone, flavanonol)], phenolic pigments (theaflavin, thearubigin, theabrownin) and purine alkaloids (caffeine, theobromine).
A total of 171 compounds have been identified in pu-erh tea, among which seven phenolic acids, 11 flavan-3-ols, and 27 flavonoids and flavonoid glycosides were identified from pu-erh tea for the first time. The exact chemical profile varies significantly depending on whether the tea is raw (sheng) or ripe (shou) and on how long it has been aged.
Aged raw pu'er tea contains approximately 210.2 mg GAE/g polyphenols, of which 2.2 mg/g are gallic acid, 16.1 mg/g theogallin, 35.1 mg/g (−)-epigallocatechin gallate (EGCG), and 40.1 mg/g (−)-epicatechin gallate, on average. Young ripened pu'er tea contains about 104.6 mg GAE/g polyphenols, of which 5.5 mg/g gallic acid, 0.9 mg/g theogallin, 0.7 mg/g (−)-epigallocatechin gallate, and 1.8 mg/g (−)-epicatechin gallate, on average.
During fermentation of ripened pu-erh tea, levels of water extract, tea polyphenols, free amino acids, catechins, caffeine, rutin, theophylline, luteolin, and myricetin decrease, while the level of soluble sugar increases. The levels of gallic acid, quercetin, ellagic acid, and kaempferol first increase and then decrease during fermentation.
Theabrownin is one of the most active and abundant pigments in Pu-erh tea. Theabrownins are high-molecular-weight, water-soluble oxidized polyphenolic pigments formed through the condensation and polymerization of theaflavins and thearubigins during the post-fermentation process. They are considered the most pharmacologically distinctive class of compounds in ripe pu-erh and are largely absent or present at much lower levels in green or black teas. The characteristic chemical profile of ripe pu-erh is rich in theabrownins, gallic acid, methoxybenzenes, and other bioactive compounds (e.g., N-acetylated amino acids, lovastatin).
The phenolic acid content in pu-erh tea (raw and ripened) includes gallic acid in raw tea. This bioactive compound is characterized by its antioxidant, antibacterial, anti-tumor, and anti-obesity aspects. The presence of vanillic acid, protocatechuic acid, dihydroxy-methoxybenzoic acid, salicylic acid, 3-hydroxybenzoic acid and isomers of dimethoxybenzoic acid were found in the matured tea, which stand out for their antimicrobial effects in the digestive tract, liver, cardiovascular, nervous systems and reproductive health and chemopreventive activity on cancer.
Tea polysaccharide (TPS), as one of the main components of tea extract, has many beneficial biological activities, including antioxidation, antidiabetic, anticancer, antiatherogenic effects, and immunomodulatory activity. The content and structure of polysaccharides differ between raw and ripe pu-erh, and between pu-erh and other tea types.
Pu-erh tea contains the purine alkaloids caffeine and theobromine. During withering, caffeine content increases, hydrolysis of hydrophobic carbohydrates begins, non-gallated catechins and aroma compounds form, and the levels of chlorophyll and various enzymes increase. The post-fermentation process further alters the alkaloid profile; levels of caffeine decrease during industrial fermentation of ripened pu-erh tea.
Lovastatin exists in red yeast rice, post-fermented pu-erh tea, oyster mushroom, and different varieties of fungi. Lovastatin is a naturally occurring HMG-CoA reductase inhibitor produced by certain fungal species involved in the post-fermentation process of ripe pu-erh. Its presence in pu-erh tea is a notable distinction from other tea types and has direct relevance to the tea's lipid-lowering activity and its safety considerations (see Section 7).
The "stale" aroma of Pu-erh tea is primarily associated with the broad class of volatile methoxybenzene compounds, involving 1,2,3-trimethoxybenzene, 1,2,3-trimethoxy-5-methylbenzene, and 4-ethyl-1,2-dimethoxybenzene. A total of 69 aroma-active compounds have been identified, with alcohols, ketones, and aldehydes being the predominant component types.
The most mechanistically characterized pathway for pu-erh tea's biological effects involves theabrownin acting on the gut microbiota and hepatic cholesterol metabolism. Theabrownin alters the gut microbiota in mice and humans, predominantly suppressing microbes associated with bile-salt hydrolase (BSH) activity. Theabrownin increases the levels of ileal conjugated bile acids (BAs) which, in turn, inhibit the intestinal FXR-FGF15 signaling pathway, resulting in increased hepatic production and fecal excretion of BAs, reduced hepatic cholesterol, and decreased lipogenesis. The inhibition of intestinal FXR-FGF15 signaling is accompanied by increased gene expression of enzymes in the alternative BA synthetic pathway, production of hepatic chenodeoxycholic acid, activation of hepatic FXR, and hepatic lipolysis.
In concrete terms: BSH enzymes are produced in intestinal microbes and function to hydrolyze conjugated BAs into unconjugated BAs. BSH microbes were suppressed by theabrownin in Pu-erh tea, resulting in the accumulation of conjugated BAs in the distal ileum. Conjugated BAs inhibited intestinal FXR-FGF15 signaling which subsequently alleviated the suppression of BA synthesis gene expression by this signaling pathway, resulting in increased BA production in the alternative synthetic pathway, fecal BA excretion, and ultimately, decreased cholesterol levels.
Bioactive components in Pu-erh tea, such as tea polyphenols, theabrownins, and tea polysaccharides, exert anti-obesity effects through multiple pathways. Pu-erh tea is rich in polyphenols and caffeine and has anti-obesity, antioxidant, and hypolipidemic activities. The possible molecular mechanisms of the anti-obesity activity include the influence of acetyl-CoA carboxylase activity by modulation of AMPK.
Based on 16S rRNA sequencing analysis, Pu-erh tea can regulate the richness and composition of the gut microbiota: on the one hand, it enriches beneficial bacteria such as Muribaculaceae, and on the other hand, it inhibits potentially harmful bacteria.
Both in vitro and in vivo experiments have substantiated the hypoglycemic effects of tea and its bioactive components through several possible mechanisms, including improvement of insulin resistance, inhibition of carbohydrate digestion and absorption (inhibition of α-amylase and α-glucosidase activity), regulation of gut microbiota, inflammatory cytokines, and gene and protein expressions in the insulin signaling pathway. Green tea's strong carbohydrate digestive enzyme inhibitory effect is linked with ellagitannins and catechins, whereas theabrownin in pu-erh tea improves fasting blood glucose (FBG) and lipid metabolism.
Epicatechin (EC), ascorbic acid, and polyphenolic compounds present in water extracts of Pu-erh tea could contribute to a protective effect on oxidative damage as well as nitric oxide scavenging. Pu-erh tea was identified as a good source of natural antioxidants. Some Pu-erh tea extracts showed dose-dependent scavenging of model free radicals such as the DPPH, superoxide, and nitrogen dioxide radicals.
Cell experiments showed that both unfermented and fermented pu-erh tea exhibit a certain degree of anti-inflammatory activity. Monascus purpureus-fermented pu-erh tea not only had better hypolipidemic and anti-atherosclerotic effects than its raw material (sun-dried green tea), but was also superior in anti-inflammatory effects to the latter, which was possibly attributable to the great changes in functional ingredients during microbial fermentation.
Pu-erh tea, a fermented tea, has beneficial effects including accommodation of the central nervous system. In one study, pu-erh tea markedly decreased the transcription and translation of mGluR5 (metabotropic glutamate receptor 5) compared to those by black and green teas. Pu-erh tea also inhibited the expression of Homer, one of the synaptic scaffolding proteins binding to mGluR5. Pu-erh tea protected neural cells from necrosis via blocked Ca²⁺ influx and inhibited protein kinase C (PKC) activation induced by excess glutamate. These findings are from preclinical (animal and cell) models; human evidence for neuroprotection is currently lacking.
Human/Clinical Evidence
In a randomized double-blind placebo-controlled study, the intervention group showed that body mass index, waist-hip ratio, fasting and 2-hour postprandial blood glucose, serum total cholesterol, triglycerides, low-density lipoprotein, and apolipoprotein B-100 all decreased in patients with metabolic syndrome, and high-density lipoprotein level increased. Serum C-reactive protein, tumor necrosis factor-α, and interleukin-6 were decreased in the intervention group. Interleukin-10 level was increased, MDA was decreased, and superoxide dismutase was increased. Compared with before treatment and the placebo group, there were significant differences (P<0.05, P<0.01).
A second study aimed to evaluate the effects of daily consumption of Puer tea extract (PTE) on body weight, body-fat composition, and lipid profile in a non-Asian population in the absence of dietary restrictions, using a randomized, double-blind, placebo-controlled study design. A total of 59 overweight or mildly obese subjects were enrolled upon screening to confirm fasting cholesterol level at or above 220 mg/dL (5.7 mmol/L). Subjects were randomized to consume PTE (3 g/day) or placebo for 20 weeks. At baseline and at 4-week intervals, blood lipids, C-reactive protein, and fasting blood glucose were evaluated. A dual-energy X-ray absorptiometry scan was performed at baseline and at study exit to evaluate changes to body composition.
In the Nature Communications mechanistic study, mice and human subjects receiving Pu-erh tea exhibited significant decreases in hepatic and serum cholesterol levels. These results confirmed other reported lipid and cholesterol-lowering effects of Pu-erh tea in both mice and human subjects. The lipid and cholesterol-lowering effects of Pu-erh tea have been shown to be of clinical value in treating obesity, fatty liver, and NAFLD. Specifically, Pu-erh tea was found to lower TG and TC levels more significantly than green, oolong, or black teas.
Preclinical Evidence
Pu-erh tea is believed to possess many beneficial health effects since it is a natural source of cardioprotective lipid-lowering and antioxidant compounds. In a rat hyperlipidemia model examining both fermented and unfermented forms, hyperlipidemic rats were treated with water extracts of either 0.5, 1.5, or 3.0 mg/kg fermented or unfermented Pu-erh tea. Serum LDL-C and triglyceride levels were significantly lowered by tea extract compared to the control group (p<0.05), and in most cases were indistinguishable from rats fed normal chow. Conversely, levels of HDL-C were elevated in the groups given daily doses of tea extract (p<0.05). Activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in serum were significantly elevated in Pu-erh tea-treated groups while levels of malondialdehyde (a byproduct of lipid peroxidation) decreased. These effects were most pronounced in the groups treated with the highest dose of fermented Pu-erh tea extract.
Evidence Assessment
Evidence for lipid-lowering effects is the most developed of all health areas for pu-erh tea. There are multiple positive human randomized controlled trials (RCTs) and a mechanistically plausible pathway involving theabrownin and bile acid metabolism published in a high-impact peer-reviewed journal. However, human trial sample sizes have generally been small, and independent large-scale replication remains limited. Evaluation of theabrownin side effects and optimal dosage for humans will require clinical trials before it can become a standard therapeutic intervention.
Human/Clinical Evidence
The randomized, double-blind, placebo-controlled metabolic syndrome trial also reported that fasting and 2-hour postprandial blood glucose decreased in patients with metabolic syndrome. Limited human trials have not convincingly demonstrated therapeutic efficiency of Pu-erh tea specifically for hyperglycemia.
Preclinical Evidence
Tea, owing to its richness of diverse bioactive components including tea polyphenols, tea polysaccharides, and alkaloids, has displayed promising antidiabetic properties. Screening antidiabetic bioactive compounds derived from teas is receiving increasing attention. Epidemiological and clinical investigations have demonstrated an inverse relationship between tea consumption and the incidence of diabetes mellitus.
Evidence Assessment
Antidiabetic effects are biologically plausible and are supported by preclinical data and epidemiological associations, but human clinical evidence specific to pu-erh tea remains preliminary and insufficient to support therapeutic claims. Limited human trials have not convincingly demonstrated therapeutic efficiency of Pu-erh tea for hyperglycemia.
Human/Clinical Evidence
Pu'er tea demonstrated potential in improving central obesity in the randomized double-blind placebo-controlled metabolic syndrome trial. The non-Asian RCT on Puer tea extract (3 g/day for 20 weeks, n=59, DEXA-measured) evaluated body fat composition as a primary endpoint in a hyperlipidemic population. Pu-erh tea is widely sold, by itself or in blends, with claims that it promotes loss of body weight in humans, although there is no accepted evidence for this.
Preclinical Evidence
Pu-erh tea administration significantly lowered plasma total cholesterol, triglyceride concentrations, and low-density lipoprotein-cholesterol levels in rats with diet-induced obesity. Moreover, pu-erh tea significantly increased lipoprotein lipase, hepatic lipase, and hormone-sensitive lipase activities in epididymal fat tissue in rats with HFD-induced obesity.
Evidence Assessment
Animal and in vitro data show consistent anti-obesity signals. Human evidence from RCTs is preliminary; some trials show positive effects on BMI and body composition, but the evidence base is not sufficient to support definitive weight-loss claims.
Evidence
In earlier screening of several teas for antioxidant activity, Pu-erh tea was identified as a good source of natural antioxidants. Some Pu-erh tea extracts showed dose-dependent scavenging of model free radicals such as the DPPH, superoxide, and nitrogen dioxide radicals. In the metabolic syndrome RCT, the antioxidant marker MDA was decreased and superoxide dismutase was increased in the intervention group.
Evidence Assessment
In vitro antioxidant capacity is well-documented. Evidence of clinically meaningful antioxidant effects in humans is limited to biomarker data in a small number of trials. In vitro antioxidant capacity does not reliably predict in vivo outcomes.
Evidence
Due to the various microorganisms involved in the post-fermentation process, Pu-erh tea contains highly complex components, which have rich interactions with the gut microbiomes. In mouse studies, the relative abundance of Lactobacillus increased significantly in mice given Pu-erh tea polyphenols orally.
The hyperlipidemic, hyperglycemic, and gut microbiota-modulating properties of ripe pu-erh tea have been corroborated in both animal and human trials. Pu-erh tea is a Chinese fermented tea that has gained attention due to its potential health benefits. It is derived from the leaves of the Camellia sinensis plant and undergoes a unique microbial fermentation process, resulting in distinct biochemical profiles.
Evidence Assessment
Gut microbiota modulation is mechanistically well-characterized, particularly through theabrownin's effects on BSH-producing microbes. Both animal and limited human data confirm changes in microbial composition. The clinical significance and durability of these effects require further large-scale human trials.
Human/Clinical Evidence
In the metabolic syndrome RCT, serum C-reactive protein, tumor necrosis factor-α, and interleukin-6 were decreased in the intervention group.
Preclinical Evidence
It is generally believed that fermented pu-erh tea can prevent obesity and reduce blood lipids more effectively, while sun-dried green tea and unfermented pu-erh tea have a better anti-inflammatory effect. However, there is not sufficient evidence to support this claim.
Evidence Assessment
Anti-inflammatory biomarker data from one human RCT are promising, but cell experiments form the primary basis of evidence. The specific contributions of fermented vs. unfermented preparations to anti-inflammatory outcomes remain inconsistent across studies.
Evidence
Pu-erh tea has attracted attention for potential biological and pharmaceutical properties, such as antimutagenic, antimicrobial, antioxidative and free radical scavenging properties, and hypolipidemic and anti-obesity effects. Phenolic acids found in matured pu-erh tea stand out for their antimicrobial effects in the digestive tract, liver, cardiovascular, nervous systems and reproductive health.
Evidence Assessment
Antimicrobial activity is predominantly demonstrated in vitro and at concentrations potentially not achievable through normal beverage consumption. No peer-reviewed human clinical trials specifically evaluating pu-erh tea as an antimicrobial intervention have been identified.
Evidence
Ripe pu-erh tea has been associated with neuroprotective and anti-mutagenic activities, along with protective effects against Alzheimer's disease. Preclinical evidence shows that pu-erh tea relieved rat epilepsy induced by LiCl-pilocarpine in behavioural and physiological assays. Pu-erh tea also decreased the expression of mGluR5 in the hippocampus. These results show that the inhibition of mGluR5 plays a role in protecting neural cells from glutamate. The results also indicate that pu-erh tea contains biological compounds binding transcription factors and inhibiting the expression of mGluR5, identifying pu-erh tea as a novel natural neuroprotective agent.
Evidence Assessment
Neuroprotective effects rest exclusively on preclinical (animal and cell-based) evidence. No human clinical trials on pu-erh tea and neurological outcomes have been identified in the peer-reviewed literature. These findings should be considered early-stage and hypothesis-generating only.
Dosages reported across human clinical research on pu-erh tea vary by preparation type. The following are reported as used in cited studies — they are not recommendations.
An increase in the content of phenolic acids can be seen after the fermentation process of pu-erh tea compared to raw tea, conferring a greater absorption of bioactive compounds. Only 20–30% of the polyphenols in tea are absorbed by the small intestine; the other components undergo microbial transformation in the colon.
Pu-Erh tea is generally considered safe, but potential adverse effects include contamination with mycotoxins, heavy metals, and possible toxicity at extremely high doses. Animal studies indicate that both raw and ripened Pu-Erh tea extracts have a high safety margin, with no observed adverse effects at doses up to 5,000 mg/kg/day for black tea extract and 2,500 mg/kg/day for green tea extract in rats. At higher doses, Pu-Erh green tea extract may cause mild liver and kidney dysfunction, body weight suppression, and calcium deposition issues, while black tea extract showed no such effects at similar doses. For reproductive and developmental toxicity, only very high doses (2,500 mg/kg/day) led to reduced body weight gain and developmental disturbances in rats, with a no-observed-adverse-effect level at 700 mg/kg/day.
Dark, black, and pu-erh tea are typically made from older leaves. Tea plants are known as fluoride hyperaccumulators, which means they absorb potential toxins and heavy metals to a greater concentration than is in the soil surrounding them. The older individual tea leaves get, the more fluoride they can absorb. The fluoride is then released during tea infusion. Bioavailability is close to 100%, because the gastrointestinal tract readily absorbs soluble fluoride.
Some pu-erh brick tea has been found to contain very high levels of fluorine, because it is generally made from lesser quality older tea leaves and stems, which accumulate fluorine. Its consumption has led to fluorosis (a form of fluoride poisoning that affects the bones and teeth) in areas of high brick tea consumption, such as Tibet.
Pu-Erh tea is produced through microbial fermentation, which can introduce contaminants. Studies have detected mycotoxins (such as patulin and asperglaucide) and heavy metals in some Pu-Erh teas, especially if storage and processing conditions are poor.
Several studies have reported that fluoride levels in some types of black tea and brick tea were unsafe for children and adults, and that long-term consumption of tea containing high levels of fluoride could result in chronic fluoride intoxication. Other major concerns include arsenic and certain heavy metals (e.g., lead, copper, chromium, cadmium). During the growth of tea plants and the procedure for tea processing, tea may be contaminated by heavy metals, such as lead and arsenic.
Lovastatin exists in red yeast rice, post-fermented pu-erh tea, oyster mushroom, and different varieties of fungi. The presence of naturally occurring lovastatin in ripe pu-erh tea is of clinical significance because lovastatin is an HMG-CoA reductase inhibitor. Emerging concerns have been raised regarding statin-induced liver toxicity (SILT) and muscle toxicity (SIMT), although the exact mechanisms have not been well understood. The specific pharmacology for different statins should be understood to maximize their benefit and minimize statin-induced toxicity. Significant toxicity may be induced by statin-drug interactions. Patients already taking statin medications should be aware that consumption of pu-erh tea may represent an additive source of HMG-CoA reductase inhibition.
Those with iron deficiency anemia should be cautious, as tea can inhibit iron absorption. Drinking pu-erh between meals rather than with iron-rich foods is advisable in such cases. This reflects the well-established binding of polyphenols (tannins) to non-heme iron in the gastrointestinal tract, a property common to all polyphenol-rich teas.
Pu-erh tea contains caffeine, and caffeine-related effects (e.g., insomnia, anxiety, palpitations, and interactions with stimulant drugs) are relevant at higher intake levels. Levels of caffeine decrease during industrial fermentation of ripened pu-erh tea, suggesting that ripe pu-erh preparations may contain somewhat less caffeine than raw preparations of equivalent leaf weight.
Because of the cultural significance of pu'er tea, its unique cultivation process, and the unbroken history of growing tea at Jingmai Mountain, it was inscribed as a UNESCO World Heritage Site in 2023. Chinese national standards define pu-erh tea by geographic origin (Yunnan Province) and processing method, which has implications for product authenticity and quality assurance in the supplement market.
Health conditions that Pu-er tea may help support.
Body systems that Pu-er tea may help support.
Go back